Biotechnology Stocks I Performance Guide: Cytokinetics, Incorporated (CYTK)
CYTK has no dividends.
Table and Chart of CYTK Performance
See what a $1,000 investment in CYTK is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CYTK Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $4.99 |
| End Date | May-10-2024 |
| End Price | $62.10 |
| # Prices | 121 |
| Min Date | Sep-30-2014 |
| Min Price | $3.52 |
| Max Date | Dec-29-2023 |
| Max Price | $83.49 |
| Total Return | 1,144.49% |
| Annualized Return | 28.41% |
| Current Value of $1,000 Purchase | $12,445 |
| Number Returns | 7,260 |
| Average Return | 197.41% |
| Number Profitable Returns | 6,233 |
| Percent Profitable Returns | 85.85% |
| Number Unprofitable Returns | 1,027 |
| Percent Unprofitable Returns | 14.15% |
| Profitable to Unprofitable Returns Ratio | 6.07 |
| CYTK Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $6,494,170,000 |
| Beta | 0.723 | Price to Sales | 993.82 |
| Earnings per Share | $-5.4000 |
| PE Ratio | None |
| PE to Growth Ratio | -0.42 |
| Price to Book | 31.9 |
| PRICE DATA | |
| 52 Week High | $110.25 |
| 52 Week Low | $25.98 |
| Analyst Target Price | $93.59 |
| 50-Day Moving Average | $67.49 |
| 200-Day Moving Average | $52.77 |
| FINANCIAL DATA | |
| Revenue per Share | $0.038 |
| Revenue | $3,752,000 |
| Profit Margin | 0% |
| Return on Equity | -572% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CYTK Compare Returns with S&P 500
CYTK Trendline Chart
CYTK Moving Average Chart
CYTK Stock Return Map - See Patterns of Gains and Losses
CYTK Stock Returns/Purchase Dates